On June 21, 2024, the 22nd CPHI China and the 17th PMEC China successfully concluded at the Shanghai New International Expo Centre. Over the course of three days, CPHI & PMEC China 2024 attracted a total of 99,749 visitors, with nearly 25% being international attendees, marking a 41.4% increase from 2023. These visitors hailed from 135 countries and regions, setting a new record and further enhancing the event's international influence and appeal.

At Booth E3A01, Grand Life Sciences (Liaoning) Co., Ltd. showcased its products and solutions in the fields of hemostasis, anesthesia, analgesia, wound management and nutritional supplements with enthusiasm and professionalism to clients and partners from various countries. During this prominent pharmaceutical event, over a hundred domestic and international companies visited our booth to inquire about product information and exchange business cards, significantly advancing our strategic layout for expanding into overseas markets. We engaged in information exchanges and business discussions with representatives from many companies in Asia, Europe, Africa, and South America, initiating preliminary negotiations on product distribution and business cooperation with some of them.

This exhibition not only demonstrated our company's strength and determination to enter the global market but also provided insights into the latest trends and demands of the international market, laying a solid foundation for future business expansion. Through interactions with international peers, GLS Liaoning discovered more potential cooperation opportunities and looks forward to deepening cooperation with both new and existing clients. We are committed to delivering higher-quality medical solutions to patients worldwide.